RT Journal Article T1 Intranasal delivery of thyroid hormones in MCT8 deficiency A1 Grijota Martínez, María Carmen A1 Bárez López, Soledad A1 Ausó, Eva A1 Refetoff, Samuel A1 Frey, William H. A1 Guadaño Ferraz, Ana A2 Iglesias Osma, Maria Carmen AB Loss of function mutations in the gene encoding the thyroid hormone transporter monocarboxylate transporter 8 (MCT8) lead to severe neurodevelopmental defects in humans associated with a specific thyroid hormone phenotype manifesting high serum 3,5,3'-triiodothyronine (T3) and low thyroxine (T4) levels. Patients present a paradoxical state of peripheral hyperthyroidism and brain hypothyroidism, this last one most likely arising from impaired thyroid hormone transport across the brain barriers. The administration of thyroid hormones by delivery pathways that bypass the brain barriers, such as the intranasal delivery route, offers the possibility to improve the neurological defects of MCT8-deficient patients. In this study, the thyroid hormones T4 and T3 were administrated intranasally in different mouse models of MCT8 deficiency. We have found that, under the present formulation, intranasal administration of thyroid hormones does not increase the content of thyroid hormones in the brain and further raises the peripheral thyroid hormone levels. Our data suggests intranasal delivery of thyroid hormones is not a suitable therapeutic strategy for MCT8 deficiency, although alternative formulations could be considered in the future to improve the nose-to-brain transport. PB Public Library of Science SN 1932-6203 YR 2020 FD 2020 LK https://hdl.handle.net/20.500.14352/92644 UL https://hdl.handle.net/20.500.14352/92644 LA eng NO Grijota-Martínez C, Bárez-López S, Ausó E, Refetoff S, Frey WH II, Guadaño-Ferraz A (2020) Intranasal delivery of Thyroid hormones in MCT8 deficiency. PLoS ONE 15(7): e0236113. https://doi.org/10.1371/journal.pone.0236113 NO Ministerio de Economía y Competitividad (España) NO Sherman Foundation NO Biotechnology and Biological Sciences Research Council (UK) NO Instituto de Salud Carlos III. NO National Institutes of Health (USA) DS Docta Complutense RD 6 abr 2025